41 Tocilizumab is a first-line drug for the treatment of cytokine release syndrome (a rapid and massive release of cytokines into the blood from immune cells, usually caused by immunotherapy), especially in patients with comorbidities. In terms of mechanism, tocilizumab binds to both the membrane...
Our results indicate a critical need for a more thorough examination of the processes by which filter-feeding organisms absorb and eliminate these pollutants, and the harmful consequences in authentic environmental contexts.The emission of exhaust particulate matter (PM), a hazardous pollutant causing ...